CanSense
PrivateLast Round
Grant
Jan 28, 2025
Total Funding Raised
$3.2M
Momentum Score
25 /100
Company Overview
CanSense is a biotechnology company that develops a non-invasive blood test using AI and laser spectroscopy for the early detection of bowel cancer.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Medical AI, Clinical Trials
Business Model
B2G
Customer Profile
Government Contracts, Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CanSense Comps
Public and private peers based on sector, stage, and business model.
CanSense Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 28, 2025 | ||||
| Grant | Nov 11, 2024 | ||||
| Seed | Mar 8, 2023 | ||||
| Grant | May 1, 2022 |
CanSense Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Welsh Government | Grant |
| Northern Ireland Department for the Economy | Grant |
| Development Bank of Wales | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 6, 2026
Monthly visitors increased 84% MoM.
CanSense Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CanSense's valuation, stock price, and market status.
